About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.
Antidepressant fluoxetine found ineffective for early COVID-19 treatment
Findings reveal fluoxetine’s weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.